Table 1 Patient characteristics at randomisation
LSVT | SLT | Control | ||
|---|---|---|---|---|
Number of patients randomised | 30 | 30 | 29 | |
Age (years) | Mean (SD) | 67 (8.4) | 68 (10.3) | 65 (7.5) |
Gender | Male (N, %) | 23 (77%) | 23 (77%) | 23 (79%) |
Body Mass Index (kg/m2) | Mean (SD) | 27.4 (4.3) | 27.6 (4.8) | 27.3 (4.2) |
Duration of PD (years) | Mean (SD) | 6.1 (3.7) | 5.6 (4.2) | 4.9 (3.4) |
Hoehn and Yahr stage | ≤ 2.0 | 20 (67%) | 16 (55%) | 20 (77%) |
2.5 | 5 (17%) | 2 (7%) | 5 (19%) | |
3.0 | 4 (13%) | 9 (31%) | 1 (4%) | |
≥ 4.0 | 1 (3%) | 2 (7%) | 0 (−) | |
Levodopa equivalent dose (mg/day)a | Mean (SD) | 695 (466.4) | 533 (328.5) | 502 (451.6) |